» Articles » PMID: 11348595

The Structure of the Beta-catenin/E-cadherin Complex and the Molecular Basis of Diverse Ligand Recognition by Beta-catenin

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2001 May 12
PMID 11348595
Citations 320
Authors
Affiliations
Soon will be listed here.
Abstract

As a component of adherens junctions and the Wnt signaling pathway, beta-catenin binds cadherins, Tcf family transcription factors, and the tumor suppressor APC. We have determined the crystal structures of both unphosphorylated and phosphorylated E-cadherin cytoplasmic domain complexed with the arm repeat region of beta-catenin. The interaction spans all 12 arm repeats, and features quasi-independent binding regions that include helices which interact with both ends of the arm repeat domain and an extended stretch of 14 residues which closely resembles a portion of XTcf-3. Phosphorylation of E-cadherin results in interactions with a hydrophobic patch of beta-catenin that mimics the binding of an amphipathic XTcf-3 helix. APC contains sequences homologous to the phosphorylated region of cadherin, and is likely to bind similarly.

Citing Articles

Wnt signaling modulates mechanotransduction in the epidermis to drive hair follicle regeneration.

Oak A, Bagchi A, Brukman M, Toth J, Ford J, Zheng Y Sci Adv. 2025; 11(8):eadq0638.

PMID: 39970220 PMC: 11838001. DOI: 10.1126/sciadv.adq0638.


Afadin mediates cadherin-catenin complex clustering on F-actin linked to cooperative binding and filament curvature.

Gong R, Reynolds M, Sun X, Alushin G Sci Adv. 2025; 11(7):eadu0989.

PMID: 39951520 PMC: 11827635. DOI: 10.1126/sciadv.adu0989.


CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomas.

Hirsch R, Premsankar S, Kurnit K, Chiou L, Rabjohns E, Lee H bioRxiv. 2024; .

PMID: 39605508 PMC: 11601622. DOI: 10.1101/2024.11.18.624183.


Programmable protein degraders enable selective knockdown of pathogenic β-catenin subpopulations and .

Ye T, Alamgir A, Robertus C, Colina D, Monticello C, Donahue T bioRxiv. 2024; .

PMID: 39605463 PMC: 11601283. DOI: 10.1101/2024.11.10.622803.


Targeting CBP and p300: Emerging Anticancer Agents.

Masci D, Puxeddu M, Silvestri R, La Regina G Molecules. 2024; 29(19).

PMID: 39407454 PMC: 11482477. DOI: 10.3390/molecules29194524.